Ghana Stock Exchange · IIL
Intravenous Infusions PLC (IIL) Share Price Today
Comparable Ghana cedis figures for Intravenous Infusions PLC are not in this set yet.
Updated on , the date of the newest filing.
No comparable cedis figures have been extracted from Intravenous Infusions PLC's filings yet.
Latest available
Latest available is the newest checked figure. Current means that period ended within about 12 months. Older filing means the last figure we have is older than that.
These latest available figures are not from the same period. Read the period beside each one.
Profit after tax
Not availableNot availableNo checked figure in full Ghana cedis.
Total assets
Not availableNot availableNo checked figure in full Ghana cedis.
Chart
A price history is not in the saved feed. The feed stores one price, so this page does not draw a price chart. The filing chart further down, when the filings support one, is profit or another filing figure. It is not the share price.
No filing chart is available for this issuer either.
About Intravenous Infusions PLC
What does this company do?
Intravenous Infusions PLC (IIL) is listed on the Ghana Stock Exchange. On this site its sector is Consumer goods. Consumer-goods companies on the Ghana Stock Exchange typically sell products people buy for the household. This page does not describe Intravenous Infusions PLC's own products.
How does it make money?
Checked profit and asset figures in full Ghana cedis are not in this set, so this page does not describe how Intravenous Infusions PLC earns money beyond its sector.
Dividends
Dividend per share is not in the saved price feed, so this page does not print one. A declaration history, with record dates and payment dates, is not in the saved data either.
A dividend yield for IIL is not in the saved market-report table.
Dividends on the Ghana Stock Exchange explains the dates and the September 2026 yields. What is a dividend? explains the word. A yield is not a reason to buy.
What the numbers mean
Kofi's glossary, not a verdict. Price-to-earnings needs earnings per share. Earnings per share is not in the saved price feed, so this page does not calculate a P/E.
A yield is not in the saved report for this symbol, so this page does not calculate one.
Profit after tax and total assets, further down, come from filings. Each one keeps its Latest available period. A bigger profit is not a reason to buy the shares.
How to buy IIL shares
Through a licensed broker. The steps are in How to buy shares on the Ghana Stock Exchange. When investing on Yanci launches, orders will go through Teak Tree Brokerage. Check that firm on the Ghana Stock Exchange and SEC lists. This page does not tell you to buy, sell or hold Intravenous Infusions PLC.
Filing alerts
Get an email when a new Ghana Stock Exchange filing for Intravenous Infusions PLC is published. Kofi does not say what to buy, sell or hold.
Facts from the filings
Key facts
- Exchange
- Ghana Stock Exchange
- Ticker
- IIL
- Sector
- Consumer goods
- Last saved share price
- GH₵0.55
- Shares in the market snapshot
- 375,074,367
How the figures move
How the figures move
Not enough comparable periods for a chart yet. The table lists what there is.
No comparable cedis figures yet. The filings are listed below. A missing number usually means the unit or the currency was not clear enough to convert.
Filings
Filings on the Ghana Stock Exchange
Each link opens the original PDF on the exchange's website.
PR-329 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE SIX MONTHS PERIOD ENDED 30 JUNE 2026
Half year ended 30 June 2026 · Unaudited · Published 31 July 2026
PR-147 INTRAVENOUS INFUSIONS PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2025
Full year ended 31 December 2025 · Published 23 April 2026
PR-018 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2025
Full year ended 31 December 2025 · Unaudited · Published 29 January 2026
PR-425 HORDS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE PERIOD 30 SEPTEMBER 2025
Third quarter ended 30 September 2025 · Unaudited · Published 6 November 2025
PR-136 INTRAVENOUS INFUSIONS PLC ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024.
Full year ended 31 December 2024 · Published 30 April 2025
PR-035 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2024.
Full year ended 31 December 2024 · Unaudited · Published 3 February 2025
Show 13 earlier filings
PR-219 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2024
Half year ended 30 June 2024 · Unaudited · Published 24 July 2024
PR-033 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2023.
Full year ended 31 December 2023 · Unaudited · Published 15 February 2024
PR-103 INTRAVENOUS INFUSIONS PLC AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2022
Full year ended 31 December 2022 · Audited · Published 14 April 2023
PR. 039/2023 INTRAVENOUS INFUSIONS PLC UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 2022.
Full year ended 31 December 2022 · Unaudited · Published 7 February 2023
PR. 287/2019-IIL – UNAUDITED FINANCIAL STATEMENTS FOR THE SECOND QUARTER ENDING 30 JUNE 2019
Half year ended 30 June 2019 · Unaudited · Published 1 August 2019
PR. 352/2018-IIL– UN-AUDITED FINANCIAL STATEMENTS FOR THE HALF YEAR ENDING JUNE 2018
Half year ended 30 June 2018 · Unaudited · Published 8 August 2018
PR. 105/2017-ILL-ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2017
Full year ended 31 December 2017 · Published 28 March 2018
PR. 290/2017-IIL-UN-AUDITED FINANCIAL STATEMENTS FOR THE HALF YEAR ENDING JUNE 2017
Half year ended 30 June 2017 · Unaudited · Published 10 August 2017
PR. 182/2017-ILL-ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2016
Full year ended 31 December 2016 · Published 2 May 2017
PR. 355/2016-IIL-UN-AUDITED FINANCIAL STATEMENTS FOR THE THIRD QUARTER ENDING SEPTEMBER 2016
Third quarter ended 30 September 2016 · Unaudited · Published 4 November 2016
PR. 265/2016-IIL-UN-AUDITED FINANCIAL STATEMENTS FOR THE HALF YEAR ENDING JUNE 2016
Half year ended 30 June 2016 · Unaudited · Published 1 August 2016
PR. No 088/2016-IIL- AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2015
Full year ended 31 December 2015 · Audited · Published 1 April 2016
PR. 045/2016-IIL-UN-AUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 2015
Full year ended 31 December 2015 · Unaudited · Published 17 February 2016
Kofi on reading these figures
Related companies
Other consumer goods
Sector: Consumer goods
- ABLAccra Brewery PLC (ABL)
- BOPPBenso Oil Palm Plantation Ltd (BOPP)
Camelot Ghana Ltd (CMLT)- CPCCocoa Processing Company (CPC)
- DASPDannex Ayrton Starwin Plc (DASPHARMA)
- FMLFan Milk Limited (FML)
- GGBLGuinness Ghana Breweries Plc (GGBL)
- KASAKasapreko PLC (KASAPREKO)
- PBCProduce Buying Company Ltd (PBC)
- PZCPZ Cussons Ghana Ltd (PZC)
- SAMBASamba Foods Ltd (SAMBA)
- SPLStarwin Products Ltd (SPL)
Unilever Ghana PLC (UNIL)
Frequently asked questions
What does Intravenous Infusions PLC do?
Intravenous Infusions PLC (IIL) is listed on the Ghana Stock Exchange. On this site its sector is Consumer goods. Consumer-goods companies on the Ghana Stock Exchange typically sell products people buy for the household. This page does not describe Intravenous Infusions PLC's own products.
How does Intravenous Infusions PLC make money?
Checked profit and asset figures in full Ghana cedis are not in this set, so this page does not describe how Intravenous Infusions PLC earns money beyond its sector.
What is the IIL share price?
The latest price we have for IIL is GH₵0.55 as of 2 November 2026 at 13:59 UTC. It can be delayed. It is not a forecast and not a recommendation.
How much is one IIL share?
The latest price we have for IIL is GH₵0.55 as of 2 November 2026 at 13:59 UTC. It can be delayed. It is not a forecast and not a recommendation.
Does Intravenous Infusions PLC pay dividends?
The saved price feed does not include a dividend per share for IIL, and a dividend yield for this symbol is not in the saved market-report table. Whether Intravenous Infusions PLC pays a dividend is decided by the company. Check its announcement.
How do I buy IIL shares?
Through a licensed broker on the Ghana Stock Exchange. The steps are in How to buy shares on the Ghana Stock Exchange. This page does not tell you to buy IIL.
Does Yanci recommend IIL?
No. This page explains Intravenous Infusions PLC using Ghana Stock Exchange filings and a saved share price. It is not a recommendation to buy, sell or hold any security.
Kofi teaches. Kofi never tells you what to buy or sell. This is education, not financial advice. Rates and prices change, so check with a licensed broker, bank, or fund manager.
Source: Ghana Stock Exchange filings, read automatically, so a number, unit or date can be misread. Figures that failed a check, or could not be put in full cedis, are left out. This page is for learning. It is not investment advice or an offer to buy or sell any security.
Kofi will walk you through companies like these in the app.
Join the waitlist for early access.